Quantcast
Last updated on April 18, 2014 at 15:27 EDT

Latest Stretta procedure Stories

2014-02-24 12:26:21

Non-Surgical Procedure Offers Patients Significant Improvement in Symptoms and Elimination or Reduction in Medication, Along With a Regression of Barrett's Metaplasia NORWALK, Conn., Feb. 24, 2014 /PRNewswire/ -- A newly-published peer-reviewed clinical study evaluated 217 patients pre-treatment and tracked them for ten years after receiving Stretta Therapy to treat gastroesophageal reflux disease (GERD). The study, entitled "Long-term maintenance effect of radiofrequency energy delivery for...

2013-12-23 12:24:10

GREENWICH, Conn., Dec. 23, 2013 /PRNewswire/ -- Mederi Therapeutics Inc. announced today the closing on $18.5 million, comprised of Series B preferred stock and venture debt. Participating in this round were Acadia Woods Partners, LLC, Respiratory Diagnostics Inc., a subsidiary of Bio-Rad Laboratories, Inc., as well as a group of high net worth equity investors. Venture debt was provided by Horizon Technology Finance. The funds will be used to support and expand on the rapidly growing...

2013-09-05 12:29:03

GREENWICH, Conn., Sept. 5, 2013 /PRNewswire/ -- A newly published peer-review study that examines Stretta therapy is bringing renewed attention to this non-surgical procedure that has 10 years of patient data and recently earned The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) highest GRADE recommendation. (Photo: http://photos.prnewswire.com/prnh/20130211/NY56794 ) The study, published in Gastroenterology Research and Practice, is titled "Stretta...

2013-05-19 08:20:16

Non-Surgical Procedure Yields High Patient Satisfaction Scores; Reduced Need for Medication; No Serious Adverse Effects ORLANDO, Fla., May 19, 2013 /PRNewswire/ -- The non-surgical Stretta® procedure employing low power and low temperature radiofrequency (RF) energy is effective in control of gastroesophageal reflux disease (GERD), and eliminates or reduces the need for medication 10 years post-procedure, according to an independent, prospective long-term assessment presented...

2013-03-04 08:29:43

GREENWICH, Conn., March 4, 2013 /PRNewswire/ -- The popular and informative MBC health program Green Apples recently aired a health segment on a common condition called Gastroesophageal Reflux Disease, or GERD. In this program, GERD was successfully treated with an innovative therapy called Stretta. Stretta uses a type of energy called radiofrequency, or RF, to remodel the valve at the top of the stomach and restore the ability to keep food contained within the stomach. Stretta is a safe and...

2013-02-11 08:26:32

GREENWICH, Conn., Feb. 11, 2013 /PRNewswire/ -- Mederi Therapeutics Inc. today announced that the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) has issued new Clinical Guidelines that strongly recommend Stretta therapy for the treatment of Gastroesophageal Reflux Disease (GERD). The SAGES Clinical Spotlight Review (CSR) process entails an in-depth analysis of the available peer-reviewed clinical evidence, focusing on randomized, controlled...

2012-10-18 07:26:48

GREENWICH, Conn., Oct. 18, 2012 /PRNewswire/ -- Mederi Therapeutics Inc. today announced the signing of an exclusive agreement with Farouq, Maamoun, Tamer & Co., for distribution of its minimally invasive therapies in the Kingdom of Saudi Arabia. Mederi manufactures the Stretta System for treatment of Gastroesophageal Reflux Disease (GERD), and the Secca System for Bowel Incontinence or Bowel Control Disorder (BCD). "As a result of a very successful physician training workshop, in which...

2012-08-09 02:27:50

GREENWICH, Conn., Aug. 9, 2012 /PRNewswire/ -- A meta-analysis published in the August issue of Surgical Laparoscopy Endoscopy and Percutaneous Techniques provides comprehensive outcomes analysis of patients who received Stretta therapy for treatment of gastroesophageal reflux disease (GERD). Stretta is a minimally invasive treatment for GERD sufferers who do not respond well to medical management. Stretta uses low temperature radiofrequency energy to remodel tissue in the lower esophageal...

2011-12-05 07:00:00

· · GREENWICH, Conn., Dec. 5, 2011 /PRNewswire/ -- Mederi Therapeutics Inc. today announced the results of a novel, double-blind, sham-controlled study of Stretta for treatment of gastroesophageal reflux disease (GERD). The study evaluated the specific mechanism of action in the application of radiofrequency (RF) energy. This ground-breaking research suggests the mechanism by which Stretta Therapy causes a decrease in...

2011-01-31 08:00:00

GREENWICH, Conn., Jan. 31, 2011 /PRNewswire/ -- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator. The Mederi RF Generator powers the Stretta® System for treatment of Gastroesophageal Reflux Disease (GERD) as well as the Secca® System for Bowel Incontinence or Bowel Control Disorder (BCD). "Today's FDA clearance of the MDRF1 is the culmination of significant investment and design efforts by...